Nyxoah SA (NYXH)
Euronext
Closed
Oct 9, 2026
Day's Range
1.2052 wk Range
1.14Overview - NYXH - Nyxoah SA
Key Statistics
Valuation
Enterprise Value
87.49M
P/E (Trailing)
‪-0.54‬
P/E (Forward)
‪-2.75‬
PEG Ratio
‪-0.11‬
Price / Sales (TTM)
‪6.13‬
Price / Book
‪1.57‬
EV / EBITDA
‪-1.05‬
Profitability
Gross Margin
‪59.72%‬
Profit Margin
‪63.13%‬
Operating Margin
‪-268.24%‬
Return on Assets
‪-36.86%‬
Return on Equity
‪-122.68%‬
Ownership
Shares Outstanding
100.07M
Float
50.88M
Held by Insiders
‪33.19%‬
Held by Institutions
‪30.87%‬
Price stats
Beta
‪1.00‬
50-Day Avg
‪1.34‬
200-Day Avg
‪2.45‬
Analyst Consensus
3 analysts
Average price target
‪€ 5.30‬Market Cap - NYXH - Nyxoah SA
Peers - NYXH - Nyxoah SA
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on Euronext.
- NYXHEuronextNyxoah SA131.37MMarket Cap-335.66%52-week change-0.55P/E (Trailing)‪63.13%‬Profit Margin
- ELEuronextEssilorLuxottica65.50BMarket Cap-93.35%52-week change26.64P/E (Trailing)‪8.51%‬Profit Margin
- DIMEuronextSartorius Stedim Biotech S.A.20.66BMarket Cap+19.47%52-week change70.33P/E (Trailing)‪9.73%‬Profit Margin
- COVEuronextCovivio4.78BMarket Cap-28.99%52-week change7.35P/E (Trailing)‪55.91%‬Profit Margin
- SOLVEuronextSolvac S.A.1.92BMarket Cap+2.22%52-week change15.36P/E (Trailing)‪3,302,181.60%‬Profit Margin
- ALCJEuronextCrossject SA79.55MMarket Cap-90.15%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- ALVMGEuronextVisiomed Group SA40.59MMarket Cap-94.64%52-week change46.67P/E (Trailing)‪45.95%‬Profit Margin
Profile Summary - NYXH - Nyxoah SA
About
Nyxoah SA is a medical technology company specializing in the development and commercialization of innovative solutions for treating obstructive sleep apnea (OSA). Its flagship product, the Genio system, offers a CE-marked, patient-centric, minimally invasive hypoglossal neurostimulation therapy designed for moderate…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
